Next Gen Immuno-Oncology Congress
In-Person Event
Jun 21 - 22, 2018
Feasterville Trevose, Pennsylvania, USA
OVERVIEW
Next Gen Immuno-Oncology Congress is organized by MarketsandMarkets (MnM) Research Private Ltd and will be held during Jun 21 - 22, 2018 at Radisson Hotel Philadelphia Northeast, Feasterville Trevose, Pennsylvania, United States of America.
The target audience for this medical event is academicians, researchers and scientists from research institute pharmaceutical, biopharmaceutical, and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiome-derived immunotherapy and new paradigms in immune checkpoint inhibitors.
Conference Description :
This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
There have been remarkable advancements in cancer immunotherapy especially in the clinical development of immune checkpoint inhibitors, neoantigen-based immunotherapy and microbiome-derived immunotherapy in cancer. One of the most promising approaches in terms of ACT (Adoptive Cell Transfer) is the CAR-T cell therapy which has recently received its second approval from the FDA.
Conference Highlights :
• Neoantigens in personalized Cancer Immunotherapy.
• Immune Checkpoint Inhibitors and Combinations (PD-1, PD-L1, PD-L4).
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immunecheckpoint modulators).
• Neoantigen Discovery by Next-Generation Sequencing.
• Biomarkers and Cancer Vaccines.
• CAR-T cell therapy, Dendritic Cell Therapy.
• Microbiome in Cancer Immunotherapy (Targets and Challenges).
• Oncolytic viruses.
• Tumor associated Macrophages as treatment in IO.
• Technologies for personalized TCR engineered cancer immunotherapies.
• Tumor microenvironment.
The target audience for this medical event is academicians, researchers and scientists from research institute pharmaceutical, biopharmaceutical, and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiome-derived immunotherapy and new paradigms in immune checkpoint inhibitors.
Conference Description :
This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
There have been remarkable advancements in cancer immunotherapy especially in the clinical development of immune checkpoint inhibitors, neoantigen-based immunotherapy and microbiome-derived immunotherapy in cancer. One of the most promising approaches in terms of ACT (Adoptive Cell Transfer) is the CAR-T cell therapy which has recently received its second approval from the FDA.
Conference Highlights :
• Neoantigens in personalized Cancer Immunotherapy.
• Immune Checkpoint Inhibitors and Combinations (PD-1, PD-L1, PD-L4).
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immunecheckpoint modulators).
• Neoantigen Discovery by Next-Generation Sequencing.
• Biomarkers and Cancer Vaccines.
• CAR-T cell therapy, Dendritic Cell Therapy.
• Microbiome in Cancer Immunotherapy (Targets and Challenges).
• Oncolytic viruses.
• Tumor associated Macrophages as treatment in IO.
• Technologies for personalized TCR engineered cancer immunotherapies.
• Tumor microenvironment.
KEY DATES
21 Jun, 2018
Event Start Date
22 Jun, 2018
Event End Date
SPECIALITIES
Immunology and MicrobiologyOncologySUGGESTED HOTELS
CONFERENCE VENUE
Radisson Hotel Philadelphia NortheastRELATED CONFERENCES & LIVE WEBINARS
Quick Links